Impact Biomedical (IBO) Non-Current Debt (2023 - 2025)
Impact Biomedical's Non-Current Debt came in at $7.97 million for Q3 2024.
Powered by 
Analysis
Impact Biomedical (IBO) Non-Current Debt (2023 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 47.86 Bn |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 35.80 Bn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 62.48 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | 51.08 Bn |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 23.68 Bn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 51.86 Bn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | 23.83 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | 60.50 Bn |
| 10 | Impact Biomedical | 397.86 Mn | 397.82 Mn | 2,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 22.88 Mn |
| Jun 30, 2025 | 22.35 Mn |
| Mar 31, 2025 | 9.14 Mn |
| Dec 31, 2024 | 12.07 Mn |
| Sep 30, 2024 | 7.97 Mn |
| Dec 31, 2023 | 12.07 Mn |
API Access
Impact Biomedical Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=IBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "IBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=IBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();